Skip to Main Content
Skip Nav Destination

Online First / Early View

Online first articles are accepted and edited, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI.

Online First

Case Reports October 3 2023
Relapse Primary Central Nervous System Lymphoma Successfully Consolidated with Allogeneic Stem Cell Transplantation with Thiotepa/Busulfan/Fludarabine Conditioning
Acta Haematol (2023) https://doi.org/10.1159/000534387
Case Reports October 3 2023
Clinico-Radio-Pathologic Correlation of Leukostasis in Acute Myeloid Leukemia with FLT3 Mutation
Acta Haematol (2023) https://doi.org/10.1159/000531832
Research Articles September 29 2023
Fostamatinib or Thrombopoietin for the Treatment of Chronic Immune Thrombocytopenia in Adult Patients: A Real-World Assessment of Safety, Effectiveness and Cost
Acta Haematol (2023) https://doi.org/10.1159/000533175
Research Articles September 28 2023
Machine Learning for the Prediction of Survival Post-Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience
Acta Haematol (2023) https://doi.org/10.1159/000533665
Brief Reports September 27 2023
Intermittent High-Dose Glucocorticoid Treatment Does Not Cause Adrenal Insufficiency in Patients with Diffuse Large B-Cell Lymphoma: A Prospective Study
Acta Haematol (2023) https://doi.org/10.1159/000534317
Research Articles September 26 2023
Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012 to 2022
Acta Haematol (2023) https://doi.org/10.1159/000533819
Research Articles September 26 2023
Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region
Acta Haematol (2023) https://doi.org/10.1159/000531675
Brief Reports September 26 2023
Limited Efficacy of Venetoclax Combination Regimens in Acute Myeloid Leukemia with Extramedullary Relapse
Acta Haematol (2023) https://doi.org/10.1159/000534026
Review Articles September 16 2023
Chronic Lymphocytic Leukemia: Disease Biology
Acta Haematol (2023) https://doi.org/10.1159/000533610
Research Articles September 14 2023
Bortezomib and Vorinostat Therapy as Maintenance Therapy Post-Autologous Transplant for Non-Hodgkin’s Lymphoma Using R-BEAM or BEAM Transplant Conditioning Regimen
Acta Haematol (2023) https://doi.org/10.1159/000533944
Case Reports September 14 2023
Cladribine, Cytarabine, and Etoposide-Based Regimens Are Safe and Tolerable In Relapsed and Refractory Acute Myeloid Leukemia Patients
Acta Haematol (2023) https://doi.org/10.1159/000534024
Editorials September 13 2023
Chronic Lymphocytic Leukemia: Novel Perspectives – How to Teach an Old Dog New Tricks
Acta Haematol (2023) https://doi.org/10.1159/000533232
Review Articles September 13 2023
Prognostic Markers in the Era of Targeted Therapies
Acta Haematol (2023) https://doi.org/10.1159/000533704
Research Articles September 12 2023
Relevant Clinical Factors in Patients with Myelofibrosis on Ruxolitinib for 5 or More Years
Acta Haematol (2023) https://doi.org/10.1159/000533875
Review Articles September 6 2023
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies
Acta Haematol (2023) https://doi.org/10.1159/000533990
Review Articles September 4 2023
Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents
Acta Haematol (2023) https://doi.org/10.1159/000533664
Research Articles August 25 2023
The Effect of Iron Overload on the Mobilization of Peripheral Blood Hematopoietic Stem Cells in Pediatric Patients with Thalassemia Major
Acta Haematol (2023) https://doi.org/10.1159/000532086
Research Articles August 21 2023
AKAP12 and IGFBP4 Are Prognostic Factors for Chronic Lymphocytic Leukemia
Acta Haematol (2023) https://doi.org/10.1159/000530618
Research Articles August 11 2023
Analysis of Hematological Indices and Splenectomy Rates in 2,130 Patients with Hemoglobin H Diseases or β-Thalassemia
Acta Haematol (2023) https://doi.org/10.1159/000533233
Case Reports August 9 2023
Treatment Outcomes of Acute Myeloid Leukemia in Patients Living with Human Immunodeficiency Virus Receiving Antiretroviral Therapy: A Single-Center Experience
Acta Haematol (2023) https://doi.org/10.1159/000533346
Research Articles August 9 2023
The Impact of Thrombocytopenia and Lymphopenia on Mortality in Patients Infected with Influenza Virus: A Retrospective Cohort Study
Acta Haematol (2023) https://doi.org/10.1159/000533466
Case Reports August 9 2023
A Case Report of Chronic Myelogenous Leukemia Presenting as Blastic Crisis with a T-Cell Acute Lymphoblastic Leukemia Phenotype: Awareness of a Rare Entity
Acta Haematol (2023) https://doi.org/10.1159/000529911
Commentaries August 7 2023
Consensus Statements Highlight the Need of Harmonizing Chronic Lymphocytic Leukemia Management Worldwide
Acta Haematol (2023) https://doi.org/10.1159/000533349
Research Articles July 31 2023
Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in Children with Severe Aplastic Anemia: A Retrospective Study
Acta Haematol (2023) https://doi.org/10.1159/000531687
Research Articles July 29 2023
Clinical Outcomes of COVID-19 in Mycosis Fungoides and Sezary Syndrome
Acta Haematol (2023) https://doi.org/10.1159/000531831
Review Articles July 27 2023
Immune Dysfunction and Infection – Interaction between CLL and Treatment: A Reflection on Current Treatment Paradigms and Unmet Needs
Acta Haematol (2023) https://doi.org/10.1159/000533234
Review Articles July 17 2023
Acute Myeloid Leukemia Treatment in the Elderly: A Comprehensive Review of the Present and Future
Acta Haematol (2023) https://doi.org/10.1159/000531628
Research Articles November 3 2022
Extracellular Vesicles Derived from Human Bone Marrow Stem Cells Inhibit Acute Lymphoblastic Leukemia Cell Growth by Inhibiting MAPK Pathway via the miR-29b-3p/GDF15 Axis
Acta Haematol (2022) https://doi.org/10.1159/000527456
Case Reports May 2 2022
Acquired Factor V Deficiency: A New Cause of Bleeding in Patients with Chronic Myeloid Leukemia and Extreme Leukocytosis
Acta Haematol (2022) https://doi.org/10.1159/000524630

Early View

Review Articles October 31 2023
Non-immunotherapy approaches for Relapsed or Refractory AML: an update for 2024
Acta Haematol (2023) https://doi.org/10.1159/000534897
Review Articles October 30 2023
Importance of MRD in the era of targeted therapies in CLL
Acta Haematol (2023) https://doi.org/10.1159/000534846
Review Articles October 27 2023
Frontline therapy in Chronic Lymphocytic Leukemia
Acta Haematol (2023) https://doi.org/10.1159/000534730
Review Articles October 17 2023
Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia: Updated German Expert Consensus on Ponatinib in CML
Acta Haematol (2023) https://doi.org/10.1159/000533666
Case Reports October 13 2023
“Don’t add fuel to the fire”- Hyperhemolysis Syndrome in a pregnant woman with compound Sickle cell disease/ß0-thalassemia - Case report and review of the literature: “Don’t add fuel to the fire”- Hyperhemolysis Syndrome in a pregnant woman
Acta Haematol (2023) https://doi.org/10.1159/000533776
Research Articles October 12 2023
Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation
Acta Haematol (2023) https://doi.org/10.1159/000534315
Review Articles October 11 2023
COVID-19 in Patients with Chronic Lymphocytic Leukemia – What Have We Learned?
Acta Haematol (2023) https://doi.org/10.1159/000534540
Review Articles October 9 2023
Cellular therapy in chronic lymphocytic leukemia: have we advanced in the last decade?
Acta Haematol (2023) https://doi.org/10.1159/000534341
Case Reports October 9 2023
Strategies to mitigate the drug-drug interaction between nirmatrelvir/ritonavir and tacrolimus in allogeneic hematopoietic stem cell transplant recipients on azole-antifungals: results of a case series
Acta Haematol (2023) https://doi.org/10.1159/000534445
Research Articles March 2 2022
Retrospective Evaluation of Oral Glucose Tolerance Test (OGTT) in Young Patients with Transfusion-Dependent Beta-Thalassemia
Acta Haematol (2022) https://doi.org/10.1159/000523874
Case Reports November 26 2021
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over
Acta Haematol (2021) https://doi.org/10.1159/000521112
Close Modal

or Create an Account

Close Modal
Close Modal